Unaudited Condensed Consolidated Statements of Stockholders' Investment - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ 397,310	$ 322,543	$ 376,231	$ 291,515
Balance - beginning of period (in shares)			27,166,538
Net income	25,497	25,573	$ 72,274	89,633
Issuance of shares through the Company's equity plans	437	617	1,861	1,525
Purchase of shares under the stock repurchase program	(31,999)	(9,049)	(53,212)	(38,458)
Settlement of net share equity awards	(17)	(12)	(2,849)	(2,081)
Excise tax on stock repurchases	(314)		(429)
Cash dividends declared	(3,091)	(3,202)	(9,435)	(9,707)
Stock-based compensation	1,230	1,364	4,612	5,407
Balance-end of period	$ 389,053	$ 337,834	$ 389,053	$ 337,834
Balance - end of period (in shares)	28,376,218	27,161,181	28,376,218	27,161,181
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period (in shares)	40,132,000	39,830,000	39,917,000	39,611,000
Balance-beginning of period	$ 401	$ 398	$ 399	$ 396
Issuance of shares through the Company's equity plans (in shares)	16,000	18,000	231,000	236,000
Issuance of shares through the Company's equity plans			$ 2	$ 2
Balance-end of period (in shares)	40,148,000	39,848,000	40,148,000	39,848,000
Balance-end of period	$ 401	$ 398	$ 401	$ 398
Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	217,986	207,678	213,182	202,729
Issuance of shares through the Company's equity plans	437	617	1,859	1,523
Stock-based compensation	1,230	1,364	4,612	5,407
Balance-end of period	219,653	209,659	219,653	209,659
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	1,177,914	1,079,872	1,137,481	1,022,317
Net income	25,497	25,573	72,274	89,633
Cash dividends declared	(3,091)	(3,202)	(9,435)	(9,707)
Balance-end of period	1,200,320	1,102,243	1,200,320	1,102,243
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ (998,991)	$ (965,405)	$ (974,831)	$ (933,927)
Balance - beginning of period (in shares)	27,668,000	27,000,000	27,167,000	26,318,000
Purchase of shares under the stock repurchase program (in shares)	708,000	161,000	1,162,000	797,000
Purchase of shares under the stock repurchase program	$ (31,999)	$ (9,049)	$ (53,212)	$ (38,458)
Settlement of net share equity awards (in shares)			47,000	46,000
Settlement of net share equity awards	(17)	(12)	$ (2,849)	$ (2,081)
Excise tax on stock repurchases	(314)		(429)
Balance-end of period	$ (1,031,321)	$ (974,466)	$ (1,031,321)	$ (974,466)
Balance - end of period (in shares)	28,376,000	27,161,000	28,376,000	27,161,000